Ravish Mani
About Ravish Mani
Data last updated:
Ravish Mani is a Managing Director at Thumbina Technologies Private Limited (since 2023) and Director at Swaad Pharmaceuticals Private Limited (since 2004). The companies operate in Chemicals. The 2 current companies with reported revenue have a combined latest revenue of ₹34.6 Lakh; the largest is Thumbina Technologies Private Limited at ₹34.2 Lakh (FY 2025). Earlier, Ravish Mani was a Director at Remiform Healthcare Private Limited (from 2009).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Thumbina Technologies Private Limited U62010JH2023PTC021753 | Managing Director | 26 Dec 2023 | 2023 | ₹34.2 Lakh (FY 2025) | Active |
| Swaad Pharmaceuticals Private Limited U24234BR1987PTC002752 | Director | 19 Oct 2004 | 1987 | ₹42,819 (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Remiform Healthcare Private Limited U24100HR2009PTC039811 | Director | 14 Dec 2009 | 2009 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ravish Mani
| Name | DIN | Company | Designation |
|---|---|---|---|
| Alka | 10440048 | Thumbina Technologies Private Limited | Director |
| Anjoo Verma | 10440049 | Thumbina Technologies Private Limited | Director |
| Dinesh Kumar Mani | 01270993 | Swaad Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ravish Mani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ravish Mani
Ravish Mani currently holds 2 directorships: Thumbina Technologies Private Limited (Managing Director, since 26 Dec 2023, revenue ₹34.2 Lakh (FY 2025)); Swaad Pharmaceuticals Private Limited (Director, since 19 Oct 2004, revenue ₹42,819 (FY 2024)).
Ravish Mani was first appointed on 19 Oct 2004 as Director at Swaad Pharmaceuticals Private Limited. The most recent appointment on record is 26 Dec 2023 at Thumbina Technologies Private Limited.
The 2 current companies of Ravish Mani that report revenue have a combined latest revenue of ₹34.6 Lakh: Thumbina Technologies Private Limited ₹34.2 Lakh (FY 2025); Swaad Pharmaceuticals Private Limited ₹42,819 (FY 2024).
Ravish Mani held 1 earlier board appointment: Remiform Healthcare Private Limited (Director, from 14 Dec 2009).
The current boards of Ravish Mani's companies include Alka (Thumbina Technologies Private Limited), Anjoo Verma (Thumbina Technologies Private Limited), Dinesh Kumar Mani (Swaad Pharmaceuticals Private Limited).